Alligator Bioscience Temporarily Halts Trial Recruitment due to COVID-19

Alligator Bioscience has temporarily halted recruitment for its ongoing phase 1 clinical trials for two drug candidates due to COVID-19.

Patients currently enrolled in clinical studies should continue with their scheduled visits, the company said, adding that it plans to resume recruitment as soon as possible.  

Alligator said it has moved to virtual operations, except for essential laboratory work.